0
     

Report Added
Report already added
G8 Countries Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

G8 Countries Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

Summary

The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The G8 countries contributed $157,809.2 million in 2021 to the global generics industry, with a compound annual growth rate (CAGR) of 3% between 2017 and 2021. The G8 countries are expected to reach a value of $180,868.4 million in 2026, with a CAGR of 2.8% over the 2021-26 period.
- Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $65,015.6 million in 2021. This was followed by Japan and Germany, with a value of $28,568.6 and $26,238.7 million, respectively.
- The US is expected to lead the generics industry in the G8 nations with a value of $71,626.7 million in 2016, followed by Japan and Germany with expected values of $31,596.4 and $30,368.1 million, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market
- Leading company profiles reveal details of key generics market players’ G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to Buy

- What was the size of the G8 generics market by value in 2021?
- What will be the size of the G8 generics market in 2026?
- What factors are affecting the strength of competition in the G8 generics market?
- How has the market performed over the last five years?
- How large is the G8 generics market in relation to its regional counterparts?

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Group of Eight (G8) Generics
2.1. Industry Outlook
3 Generics in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Generics in France
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Generics in Germany
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Generics in Italy
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Generics in Japan
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Generics in Russia
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
14 Macroeconomic Indicators
14.1. Country data
15 Generics in The United Kingdom
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
16 Macroeconomic Indicators
16.1. Country data
17 Generics in The United States
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis
18 Macroeconomic Indicators
18.1. Country data
19 Company Profiles
20 Appendix
20.1. Methodology
20.2. About MarketLine

List of Tables
Table 1: G8 generics industry, revenue($m), 2017-26
Table 2: G8 generics industry, revenue by country ($m), 2017-21
Table 3: G8 generics industry forecast, revenue by country ($m), 2021-26
Table 4: Canada generics market value: $ million, 2016-21
Table 5: Canada generics market volume: %, 2016-21
Table 6: Canada generics market geography segmentation: $ million, 2021
Table 7: Canada generics market value forecast: $ million, 2021-26
Table 8: Canada generics market volume forecast: %, 2021-26
Table 9: Canada size of population (million), 2017-21
Table 10: Canada gdp (constant 2005 prices, $ billion), 2017-21
Table 11: Canada gdp (current prices, $ billion), 2017-21
Table 12: Canada inflation, 2017-21
Table 13: Canada consumer price index (absolute), 2017-21
Table 14: Canada exchange rate, 2017-21
Table 15: France generics market value: $ million, 2016-21
Table 16: France generics market volume: %, 2016-21
Table 17: France generics market geography segmentation: $ million, 2021
Table 18: France generics market value forecast: $ million, 2021-26
Table 19: France generics market volume forecast: %, 2021-26
Table 20: France size of population (million), 2017-21
Table 21: France gdp (constant 2005 prices, $ billion), 2017-21
Table 22: France gdp (current prices, $ billion), 2017-21
Table 23: France inflation, 2017-21
Table 24: France consumer price index (absolute), 2017-21
Table 25: France exchange rate, 2017-21
Table 26: Germany generics market value: $ billion, 2016-21
Table 27: Germany generics market volume: %, 2016-21
Table 28: Germany generics market geography segmentation: $ billion, 2021
Table 29: Germany generics market value forecast: $ billion, 2021-26
Table 30: Germany generics market volume forecast: %, 2021-26
Table 31: Germany size of population (million), 2017-21
Table 32: Germany gdp (constant 2005 prices, $ billion), 2017-21
Table 33: Germany gdp (current prices, $ billion), 2017-21
Table 34: Germany inflation, 2017-21
Table 35: Germany consumer price index (absolute), 2017-21
Table 36: Germany exchange rate, 2017-21
Table 37: Italy generics market value: $ million, 2016-21
Table 38: Italy generics market volume: %, 2016-21
Table 39: Italy generics market geography segmentation: $ million, 2021
Table 40: Italy generics market value forecast: $ million, 2021-26
Table 41: Italy generics market volume forecast: %, 2021-26
Table 42: Italy size of population (million), 2017-21
Table 43: Italy gdp (constant 2005 prices, $ billion), 2017-21
Table 44: Italy gdp (current prices, $ billion), 2017-21
Table 45: Italy inflation, 2017-21
Table 46: Italy consumer price index (absolute), 2017-21
Table 47: Italy exchange rate, 2017-21
Table 48: Japan generics market value: $ billion, 2016-21
Table 49: Japan generics market volume: %, 2016-21
Table 50: Japan generics market geography segmentation: $ billion, 2021
Table 51: Japan generics market value forecast: $ billion, 2021-26
Table 52: Japan generics market volume forecast: %, 2021-26
Table 53: Japan size of population (million), 2017-21
Table 54: Japan gdp (constant 2005 prices, $ billion), 2017-21
Table 55: Japan gdp (current prices, $ billion), 2017-21
Table 56: Japan inflation, 2017-21
Table 57: Japan consumer price index (absolute), 2017-21
Table 58: Japan exchange rate, 2017-21
Table 59: Russia generics market value: $ million, 2016-21
Table 60: Russia generics market volume: %, 2016-21
Table 61: Russia generics market geography segmentation: $ million, 2021
Table 62: Russia generics market value forecast: $ million, 2021-26
Table 63: Russia generics market volume forecast: %, 2021-26
Table 64: Russia size of population (million), 2017-21
Table 65: Russia gdp (constant 2005 prices, $ billion), 2017-21
Table 66: Russia gdp (current prices, $ billion), 2017-21
Table 67: Russia inflation, 2017-21
Table 68: Russia consumer price index (absolute), 2017-21
Table 69: Russia exchange rate, 2017-21
Table 70: United Kingdom generics market value: $ billion, 2016-21
Table 71: United Kingdom generics market volume: %, 2016-21
Table 72: United Kingdom generics market geography segmentation: $ billion, 2021
Table 73: United Kingdom generics market value forecast: $ billion, 2021-26
Table 74: United Kingdom generics market volume forecast: %, 2021-26
Table 75: United Kingdom size of population (million), 2017-21
Table 76: United Kingdom gdp (constant 2005 prices, $ billion), 2017-21
Table 77: United Kingdom gdp (current prices, $ billion), 2017-21
Table 78: United Kingdom inflation, 2017-21
Table 79: United Kingdom consumer price index (absolute), 2017-21
Table 80: United Kingdom exchange rate, 2017-21

List of Figures
Figure 1: G8 generics industry, revenue($m), 2017-26
Figure 2: G8 Generics industry, revenue by country (%), 2021
Figure 3: G8 generics industry, revenue by country ($m), 2017-21
Figure 4: G8 generics industry forecast, revenue by country ($m), 2021-26
Figure 5: Canada generics market value: $ million, 2016-21
Figure 6: Canada generics market volume: %, 2016-21
Figure 7: Canada generics market geography segmentation: % share, by value, 2021
Figure 8: Canada generics market value forecast: $ million, 2021-26
Figure 9: Canada generics market volume forecast: %, 2021-26
Figure 10: Forces driving competition in the generics market in Canada, 2021
Figure 11: Drivers of buyer power in the generics market in Canada, 2021
Figure 12: Drivers of supplier power in the generics market in Canada, 2021
Figure 13: Factors influencing the likelihood of new entrants in the generics market in Canada, 2021
Figure 14: Factors influencing the threat of substitutes in the generics market in Canada, 2021
Figure 15: Drivers of degree of rivalry in the generics market in Canada, 2021
Figure 16: France generics market value: $ million, 2016-21
Figure 17: France generics market volume: %, 2016-21
Figure 18: France generics market geography segmentation: % share, by value, 2021
Figure 19: France generics market value forecast: $ million, 2021-26
Figure 20: France generics market volume forecast: %, 2021-26
Figure 21: Forces driving competition in the generics market in France, 2021
Figure 22: Drivers of buyer power in the generics market in France, 2021
Figure 23: Drivers of supplier power in the generics market in France, 2021
Figure 24: Factors influencing the likelihood of new entrants in the generics market in France, 2021
Figure 25: Factors influencing the threat of substitutes in the generics market in France, 2021
Figure 26: Drivers of degree of rivalry in the generics market in France, 2021
Figure 27: Germany generics market value: $ billion, 2016-21
Figure 28: Germany generics market volume: %, 2016-21
Figure 29: Germany generics market geography segmentation: % share, by value, 2021
Figure 30: Germany generics market value forecast: $ billion, 2021-26
Figure 31: Germany generics market volume forecast: %, 2021-26
Figure 32: Forces driving competition in the generics market in Germany, 2021
Figure 33: Drivers of buyer power in the generics market in Germany, 2021
Figure 34: Drivers of supplier power in the generics market in Germany, 2021
Figure 35: Factors influencing the likelihood of new entrants in the generics market in Germany, 2021
Figure 36: Factors influencing the threat of substitutes in the generics market in Germany, 2021
Figure 37: Drivers of degree of rivalry in the generics market in Germany, 2021
Figure 38: Italy generics market value: $ million, 2016-21
Figure 39: Italy generics market volume: %, 2016-21
Figure 40: Italy generics market geography segmentation: % share, by value, 2021
Figure 41: Italy generics market value forecast: $ million, 2021-26
Figure 42: Italy generics market volume forecast: %, 2021-26
Figure 43: Forces driving competition in the generics market in Italy, 2021
Figure 44: Drivers of buyer power in the generics market in Italy, 2021
Figure 45: Drivers of supplier power in the generics market in Italy, 2021
Figure 46: Factors influencing the likelihood of new entrants in the generics market in Italy, 2021
Figure 47: Factors influencing the threat of substitutes in the generics market in Italy, 2021
Figure 48: Drivers of degree of rivalry in the generics market in Italy, 2021
Figure 49: Japan generics market value: $ billion, 2016-21
Figure 50: Japan generics market volume: %, 2016-21
Figure 51: Japan generics market geography segmentation: % share, by value, 2021
Figure 52: Japan generics market value forecast: $ billion, 2021-26
Figure 53: Japan generics market volume forecast: %, 2021-26
Figure 54: Forces driving competition in the generics market in Japan, 2021
Figure 55: Drivers of buyer power in the generics market in Japan, 2021
Figure 56: Drivers of supplier power in the generics market in Japan, 2021
Figure 57: Factors influencing the likelihood of new entrants in the generics market in Japan, 2021
Figure 58: Factors influencing the threat of substitutes in the generics market in Japan, 2021
Figure 59: Drivers of degree of rivalry in the generics market in Japan, 2021
Figure 60: Russia generics market value: $ million, 2016-21
Figure 61: Russia generics market volume: %, 2016-21
Figure 62: Russia generics market geography segmentation: % share, by value, 2021
Figure 63: Russia generics market value forecast: $ million, 2021-26
Figure 64: Russia generics market volume forecast: %, 2021-26
Figure 65: Forces driving competition in the generics market in Russia, 2021
Figure 66: Drivers of buyer power in the generics market in Russia, 2021
Figure 67: Drivers of supplier power in the generics market in Russia, 2021
Figure 68: Factors influencing the likelihood of new entrants in the generics market in Russia, 2021
Figure 69: Factors influencing the threat of substitutes in the generics market in Russia, 2021
Figure 70: Drivers of degree of rivalry in the generics market in Russia, 2021
Figure 71: United Kingdom generics market value: $ billion, 2016-21
Figure 72: United Kingdom generics market volume: %, 2016-21
Figure 73: United Kingdom generics market geography segmentation: % share, by value, 2021
Figure 74: United Kingdom generics market value forecast: $ billion, 2021-26
Figure 75: United Kingdom generics market volume forecast: %, 2021-26
Figure 76: Forces driving competition in the generics market in the United Kingdom, 2021
Figure 77: Drivers of buyer power in the generics market in the United Kingdom, 2021
Figure 78: Drivers of supplier power in the generics market in the United Kingdom, 2021
Figure 79: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2021
Figure 80: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2021

Report Title: G8 Countries Generics Market Summary, Competitive Analysis and Forecast, 2017-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM